The coronavirus has exposed a dangerous risk to the national security and safety of United States citizens: the dependency on China to produce our pharmaceutical products. According to the Food and Drug Administration, at least 80% of the active ingredients found in all of America's medicines come from abroad - primarily China (Fox News). The United States Federal Government has a unique opportunity to change the course of this alarming trend - while providing a major stimulus for our country.

We are proposing that the President of the United States work in conjunction with Congress on a bipartisan basis to pass legislation that immediately funds the reshoring of pharmaceutical production to ensure that 90% of necessary products are developed domestically.